EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grantcharova, E.
Right arrow Articles by Oksche, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grantcharova, E.
Right arrow Articles by Oksche, A.
Experimental Biology and Medicine 231:757-760 (2006)
© 2006 Society for Experimental Biology and Medicine


BASIC BIOLOGY

Endothelin A and Endothelin B Receptors Differ in Their Ability to Stimulate ERK1/2 Activation

Evelina Grantcharova*,{dagger}, H. Peter Reusch{ddagger}, Michael Beyermann{dagger}, Walter Rosenthal*,{dagger} and Alexander Oksche*,{dagger},1

* Institut für Pharmakologie, Charité Campus Benjamin Franklin, 14195 Berlin, Germany; {dagger} Forschungsinstitut für Molekulare Pharmakologie, Campus Berlin-Buch, 13125 Berlin, Germany; and {ddagger} Abteilung für Klinische Pharmakologie, Ruhr-Universität Bochum, 44801 Bochum, Germany

To whom requests for reprints should be addressed at 1 Institut für Pharmakologie, Charité Campus Benjamin Franklin, Thielallee 67-73, 14195 Berlin, Germany. E-mail: alexander.oksche{at}charite.de

Abstract

Endothelin-1 (ET-1) acts on two different G protein–coupled receptors, namely the endothelin A (ETA) and the endothelin B (ETB) receptors. Both receptor subtypes show differences in their tissue expression and signal transduction. In the present study, we compared the ability of ETA and ETB receptors to stimulate extracellular signal-regulated kinase 1/2 (ERK1/2). In addition, we analyzed the role of the extracellular N terminus for ERK1/2 activation, because the ETB receptor undergoes an agonist-dependent N-terminal proteolysis. ET-1 stimulation of HEK293 cells stably expressing the ETA receptor induced a monophasic, but sustained ERK1/2 activation, whereas the ETB receptor showed a biphasic ERK1/2 activation. A truncated mutant ETB receptor, lacking the proteolytically cleaved N terminus ({Delta}2-64 ETB) revealed only a monophasic and transient ERK1/2 activation. Treatment of HEK293 {Delta}2-64 ETB cell clones with ET-1 and a synthetic NT27-64 peptide, corresponding to the N-terminally cleaved fragment of the ETB receptor and ET-1, did not restore the biphasic activation of ERK1/2. A chimeric ETB receptor in which the N terminus was replaced by the N terminus of the ETA receptor elicited biphasic ERK1/2 activation. The presented data suggest that an intact N terminus of the ETB receptor is necessary for the second phase of ERK1/2 activation. However, it appears that the length of the N terminus rather than a specific sequence motif is required for biphasic ERK1/2 activation.

Key Words: endothelin • glycosylation • G protein-coupled receptor • MAPK







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.